Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cellectar Biosciences

0.2642
+0.01265.01%
Volume:360.99K
Turnover:94.26K
Market Cap:12.17M
PE:-0.19
High:0.2676
Open:0.2580
Low:0.2538
Close:0.2516
Loading ...
May 14, 2020

Major Issues Report

8-K - Current report
May 08, 2020

Public Prospectus

General form for registration of securities under the Securities Act of 1933
May 07, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 07, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Mar 09, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 09, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Feb 20, 2020

Major Issues Report

Current report, items 7.01 and 9.01
Feb 19, 2020

Major Issues Report

Current report, items 7.01 and 9.01
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 11, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 11, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 07, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 09, 2020

Major Issues Report

Current report, items 7.01 and 9.01
Jan 07, 2020

Major Issues Report

Current report, items 5.02 and 9.01
Jan 06, 2020

Major Issues Report

Current report, items 7.01 and 9.01
Dec 19, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Dec 16, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Dec 09, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Dec 04, 2019

Major Issues Report

Current report, items 7.01 and 9.01